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Abstract
Background: The aim of this case report is to discuss the issue of nutritional therapy in patients taking warfarin.
Patients are often prescribed vitamin K free diets without nutritional counseling, leading to possible health consequences.
Case presentation: A 52-year-old woman with obesity and hypertension was prescribed a low calorie diet by her family
doctor in an effort to promote weight loss. After a pulmonary embolism, she was placed on anticoagulant therapy and
on hospital discharge she was prescribed a vitamin K free diet to avoid interactions. Given poor control of
her anticoagulant therapy, she was referred to our Nutritional Unit outpatients’ service.
Conclusions: This case illustrates the importance of a thorough medical nutrition assessment in the management of
patients with obesity and the need for a change in the dietary approach of nutritional therapy in the management of
vitamin K anticoagulant therapy. In patients taking warfarin, evidence suggest that the aim of nutritional therapy
should be to keep dietary intake of vitamin K constant.
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Background
A number of studies have found a significant increased
risk for deep venous thromboembolism (VTE), and/or
pulmonary embolism in people with obesity [1–6]. A
hazard ratio of 2.7 for a body mass index >40 has been
reported by the Atherosclerosis Risk in Communities
(ARIC) and the Cardiovascular Health Study (CHS) [2].
Besides obesity, many other factors contribute to in-
creasing the VTE risk: smoking, increasing age, patients
with factor V Leiden or pro-thrombin gene mutation [7]
and oral contraceptive therapy [8].
Patients who had a VTE episode are usually treated with
oral anticoagulants. Their use is challenging because the
therapeutic range is narrow and dosing is affected by
multiple factors including genetic variation, drug inter-
actions, and diet [9]. Moreover, compared to normal
weight, obese and morbidly obese patients had a de-
creased initial response to warfarin [10, 11].
Prothrombin time is an assay evaluating the extrin-
sic pathway of coagulation. The international normalized
ratio (INR) is used to standardize the prothrombin
time and the optimal intensity of anticoagulant
therapy corresponds to a target INR of 2.5 (range,
2.0 to 3.0) [12].
Both prophylaxis and treatment of VTE and pulmon-
ary embolism (PE) with anticoagulants are associated
with significant risks of major and fatal hemorrhage.
Both anticoagulant treatment and lifestyle changes
should be individualized to prevent further complica-
tions [9, 12].
Two major factors that may lead to poor INR control
are failure to take warfarin appropriately and very low
dietary vitamin K intake/vitamin K deficiency. The nutri-
tional management of these patients is therefore ex-
tremely complicated.
We hereby describe a case of pulmonary embolism in
an obese patient providing key insights into treatment
with medical nutrition therapy and anticoagulants.
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Case presentation
In-patient diagnosis and treatment
In January 2015, a 52-year old woman with obesity and
hypertension was admitted to the cardiac intensive care
unit of a hospital in Northern Italy for acute dyspnea
and chest pain. Computed tomography angiography
revealed filling defects affecting the right and left
branches of the pulmonary artery suggestive of pul-
monary embolism (PE). She was initially treated with
intravenous heparin sodium and bridged to warfarin as
a long-term anticoagulant. Before the hospital discharge
she was prescribed a vitamin K free diet reported in
Table 1(b). Although the general recommendation is to
maintain a stable and consistent intake of Vitamin K, in
the clinical practice patients are suggested to avoid food
high in vitamin K and they are given general dietetic
guidelines.
During her first month as an outpatient it was very
difficult to get her INR into the therapeutic range. Her
family doctor recognized that poor nutrition is an
important factor in establishing therapeutic levels and
she was referred to our Nutritional Unit outpatient ser-
vice (NU) for a nutritional assessment and specific med-
ical nutrition therapy. Figure 1 shows the timeline of
present illness, intervention and follow-up.
Outpatient nutritional unit
Medical history
She reported a long-term history of obesity and hyper-
tension. She denied allergies and cigarette smoking and
reported a sedentary lifestyle with no physical activity.
The patient was nulliparous and had been on oral
contraceptive therapy since the age of 25. The therapy
was discontinued by her physicians after her PE. At
the time of the examination she was on nebivolol, al-
prazolam and warfarin adjusted for INR, as well as
vitamin B12 and folate supplementation (400 μg). Her
family history was negative for thrombosis and car-
diovascular diseases.
Table 1 Total energy and nutrient composition of three diets prescribed to a 52-year-old woman before (a) and after (b, c) a
pulmonary embolism
(a) Low calorie diet (b) vitamin K free diet (c) NU diet
Nutrients Amount (units) % of total energy Amount (units) % of total energy Amount (Units) % of total energy
Energy 1044 (kcal) 922 (kcal) 1688 (kcal)
Proteins 50 (g) 19 30 (g) 13 77 (g) 18
Animal proteins 34 (g) 17 (g) 46 (g)
Vegetable proteins 16 (g) 13 (g) 31 (g)
Fats 37 (g) 32 37 (g) 36 50 (g) 26
Animal fats 13 (g) 32 (g) 12 (g)
Vegetable fats 24 (g) 5 (g) 38 (g)
Saturated fats 11 (g) 9.5 18 (g) 17 11 (g) 6.0
Monounsaturated fats 20 (g) 17 10 (g) 10 30 (g) 16.0
Linoleic acid 3 (g) 2.5 3.0 (g) 3.0 6 (g) 3.0
Linolenic acid 1 (g) 1.0 1.0 (g) 1.0 1 (g) 0.5
Polyunsaturated fats 4 (g) 3.5 4.0 (g) 4.0 8 (g) 4.0
Cholesterol 97 (mg) 103 (mg) 236 (mg)
Carbohydrates 139 (g) 50 127 (g) 51 250 (g) 56
Soluble carbohydrates 42 (g) 15 41 (g) 17 52 (g) 11
Dietary fiber 16 (g) 14 (g) 23 (g)
Thiamine 0.6 (mg) 1.1 (mg) 1.0 (g)
Vitamin B6 1.5 (mg) 1.1 (mg) 1.9 (g)
Folate 253 (μg) 87 (μg) 264 (g)
Vitamin K 273 (μg) 23 (μg) 58 (μg)
Sodium 1880 (mg) 3415 (mg) 1460 (g)
a) Low calorie diet prescribed the patient by her family doctor before the pulmonary embolism. b) Vitamin K free diet prescribed upon discharge to the patient
taking oral anticoagulants after the pulmonary embolism. c) Diet prescribed by the Nutritional Unit (NU) to the same patient: moderately low calorie with low
vitamin K (planning a slow and continuous increase of vitamin K daily intake up to 150 μg per day)
Diet composition analyzed by trained dietitians using a dedicated software developed by our Nutrition Unit incorporating “Food Composition Database for
Epidemiological Studies in Italy” by Gnagnarella P, Salvini S, Parpinel M. Version 1.2015 Website http://www.bda-ieo.it/
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Weight history
The patient reported that she began struggling with
obesity during her childhood. She began adulthood at a
weight of 90 kg (BMI 35.0 kg/m2). Maximum and mini-
mum weight reported by the patient were 117.5 kg (BMI
45.9 kg/m2) and 69 kg (BMI 27.0 kg/m2) respectively at
51 and 26 years of age. Soon after reaching her peak
weight she started a hypocaloric diet as suggested by her
family doctor, Table 1(a).
Nutritional assessment
Anthropometrical, bioelectrical and clinical findings at
physical examination are showed in Table 2 with bio-
chemical analyses. The patient’s BMI was greater than
34.99 Kg/m2, class II obesity according to WHO classifi-
cation [13]. Fat mass was estimated by bioelectrical im-
pedance analysis (BIA) using a BIA 101 Akern s.r.l.
(Italy). The exam, performed under standardized condi-
tions [14] revealed an important increase in fat mass al-
though a normal state of hydration. The waist-to-hip
ratio indicates an android fat distribution. Evidence of
increased visceral fat depot is shown by waist circumfer-
ence measurement.
Resting energy expenditure (REE) has been estimated
by means of Mifflin predictive equations [15], which is
more likely than the other known equations to estimate
REE to within 10 % [16].
Before the PE, the patient was following the diet re-
ported in Table 1(a), which was prescribed by her
family doctor. Total energy and nutrient intakes were
analyzed by trained dietitians using dedicated software
developed by our Nutrition Unit incorporating “Food
Composition Database for Epidemiological Studies in
Italy” by Gnagnarella P, Salvini S, Parpinel M. (Version
1.2015 Website http://www.bda-ieo.it/).
The diet followed by the patient before the PE was
a low-calorie diet that did not satisfy the dietary rec-
ommendations for protein and micronutrient intake
(LARN 2014) [17].
The nutrient composition of the diet prescribed to the
patient after the PE upon hospital discharge is reported
in Table 1(b).
Vitamin K free diets typically are lacking in vegeta-
bles, with a consequent insufficient dietary fiber and
folate intake. Protein intake prescribed to the patient
was far lower than any standard recommendation
(less than 0.33 g/ kg of body weight) while the total
fat and in particular the saturated ones were higher
than the standard recommendations (LARN 2014 and
ESC 2012 [18]).
The patient’s laboratory values at the time of her first
examination in our NU are shown in Table 2. She had
high levels of homocysteine and low prealbumin. She
also was vitamin D deficient as can be seen in patients
with obesity [19].
Both folate and vitamin B12 concentrations levels were
within the accepted normal ranges, likely due to her
supplementation and not her dietary intake.
Therapeutic intervention
After the nutritional assessment, a balanced, low-calorie
diet was prescribed, with particular attention to sodium
and soluble carbohydrates intake. The protein intake
prescribed was equivalent to 0.8 g/Kg of actual body
weight. The nutritional composition of the diet pre-
scribed at our NU is shown in Table 1(c).
In order to avoid a sharp change in vitamin K intake the
starting vitamin K intake prescribed was low (57.88 μg per









NU vitamin K constant diet
February 20th, 2015
INR out of range INR inside range
INR: International normalized ratio. INR therapeutic range: 2.0 –3.0
NU: Nutritional unit outpatients’ service
PE: Pulmonary embolism 
Fig. 1 Timeline
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150 μg per day. Folate supplementation was prescribed
(400 μg per day) as well as vitamin D supplementation
(300,000 IU every 3 months for 9 months) [20].
The benefit of having her seen in the NU was that our
staff was able to take the appropriate amount of time to
counsel the patient and to ensure she understood the
dietary guidelines and risk of complications in order to
transform the acquired knowledge into behavior change
and to achieve greater adherence.
Follow-up and outcomes
The patient’s INR values were tested on a regular base.
As shown in Table 3, the INR values were therapeutic
and remained constant immediately following initiation
of the prescribed diet.
Conclusion
This case study presents the nutritional issues of antico-
agulants in the setting of obesity. We present a case of a
52 year old female patient with obesity and hypertension
taking anticoagulants due to a history of a recent PE
treated in our NU outpatient service.
She had no inherited thrombophilia nor a previous
hospitalization, immobility, trauma, surgery, malignancy
or infection before the PE, and we hypothesize that per-
haps this adverse event might have been caused by the
combination of obesity, oral contraceptive therapy and
sedentary lifestyle. Indeed, there is strong evidence that
oral contraceptives entail a statistically significant risk of
VTE, which is particularly high among women with high
body mass indices and a history of cigarette smoking
[21, 22]. Previous studies demonstrate that oral contra-
ceptives modify the effect of obesity on the risk of ven-
ous thrombosis, with a 10-fold increased risk among
women on oral contraceptives with a BMI >25 kg/m2
compared to normal weight women not using oral con-
traceptives [8, 23].
Obesity is considered a risk factor for VTE and PE
and is associated with an increase of procoagulant fac-
tors (factor VII, factor VIII, factor XII and fibrinogen)
[24–26] and with venous stasis [2] in turn increasing the
thrombotic risk (Virchow’s triad). Analysis of data from
the National Hospital Discharge Survey indicated an in-
creased relative risk for VTE (RR 2.50, 95 CI 2.492.51)
and PE (RR 2.21, 95 % CI 2.202.23) in subjects with
obesity [27].
Table 2 Clinical findings and blood test results at the time of





Mean cellular volume 83.2 (fl)
Platelets 250 (1000/ μl)
Leukocytes 8.81 (1000/ μl)
International normalized ratio 2.06








Vitamin B12 372 (pg/ml)











Body mass index: 36.6 kg/m2
aBlood pressure: 120/70 mmHg
Waist circumference: 122 cm
Hip circumference: 118 cm
Waist-to-Hip ratio: 1.03
bResting Energy Expenditure (REE):
1515 kcal/day
cEnergy Expenditure: 1818 kcal/day
dBIA for BC FM = 48.2 % PhA = 5.5°
VR506Q mutation of factor V (Leiden): absent
VH1299R mutation of factor V: absent
G20210 of protrhombin gene (factor II): absent
Methylene tetrahydrofolate reductase (MTHFR) gene mutation: absent
Fifty-two-year old female patient with obesity and hypertension taking
anticoagulants due to a history of a recent pulmonary embolism
ataking hypertension medication
bMifflin equation [14].
cEE = REE x Activity Factor Category Definition (1.2 for sedentary)
dBioelectrical Impedance Analysis for Body Composition (BIA 101 Akern s.r.l. – Italy);
FM = Fat mass, PhA = Phase angle
Table 3 INR testing in a 52-year old woman taking oral antico-
agulants due to a recent history of pulmonary embolism










Before February 20th, she was fallowing a vitamin K free diet. After February
20th, she was following the diet prescribed at our nutritional unit (NU), with
stable content of vitamin K
INR = International normalized ratio. INR therapeutic range: 2.0 – 3.0
Warfarin dose refers to the week prior to the INR value
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Our patient reported a long history of obesity and 7
months before the PE episode she was put on a low cal-
orie diet without a formal nutritional assessment of her
specific nutritional needs.
As shown in Table 1, the diet before the PE did
not satisfy fiber, protein and micronutrients needs for
this patient likely due to the low fruit and vegetable
intake.
The “Longitudinal Investigation of Thromboembolism
Etiology (LITE)” prospective study [28] found a diet with
more fruits, vegetables, and fish, and less red and proc-
essed meat was associated with a lower VTE incidence.
Data about the relationship of diet to VTE risk comes
from: historical observations about the incidence of PE
under wartime conditions, including food rationing in
early 20th century European cities; prospective observa-
tional studies of diet and lifestyle factors associated with
VTE [9]; case–control studies of VTE patients looking
at lipid profiles, inflammation markers, and coagulation
variables; comparisons among the general population on
various diets regarding lipid profiles, inflammation
markers, and coagulation variables [9]. It is possible that
the link between diet and VTE is potentially through
other aspects of their lifestyle: people who are less health
conscious may be less concerned about a healthy diet
and may place less importance as well on physical activ-
ity, exposing them to a greater risk of prolonged non-
pulsatile venous blood flow and consequent valve pocket
hypoxemia. According to the valve cusp hypoxia hypoth-
esis (VCHH) deep venous thromboembolism may occur
wherever sustained non-pulsatile venous blood flow
leads to suffocating hypoxemia in the valve pockets,
resulting in hypoxic injury to and hence death of the
inner endothelium of the cusp leaflets [9].
Furthermore both diets before and after the PE
were very high in sodium intake, which would be in-
appropriate in a patient with a long history of hyper-
tension. Our patient also had hyperhomocysteinemia,
despite vitamin B12 and folate supplementation. High
plasma concentration of homocysteine may be due to
genetic defects in the enzymes involved in homocyst-
eine metabolism (i.e. homozygosity for the thermo-
labile variant of methylene tetrahydrofolate reductase,
MTHFR -TT genotype), nutritional deficiencies in
vitamin cofactors (folate, vitamin B6, and vitamin
B12 [29–32]), or other factors including some drugs
such as oral contraceptives. Given her absence of
MTHFR mutation, it is most likely her hyperhomo-
cysteinemia was due to both the long-term oral
contraceptive therapy and to a low folate diet. Since
prothrombotic effects of homocysteine have been
demonstrated [33–36], it is important to include this
parameter in the nutritional assessment. Indeed, a
proper assessment of patients with obesity should
include vitamin status especially in those at risk of
subclinical deficiencies.
This case illustrates the need for a thorough med-
ical nutrition assessment in the management of pa-
tients with obesity. Weight loss therapy, cannot be
focused only on lowering calories, but should include
care to meet macro and micronutrients recommenda-
tions even through supplementation, if necessary.
A vitamin K free diet, such as Table 1(b), is very often
prescribed to patients who had a PE and are on warfarin.
Individuals on warfarin generally are sensitive to fluctua-
tions in vitamin K intake, and adequate INR control re-
quires close attention to the amount of vitamin K
ingested from dietary and other sources [37]. This case
report highlights the need for a change in the clinical ap-
proach of patients taking warfarin. The aim of nutri-
tional therapy should be to keep dietary intake of
vitamin K constant rather than to exclude it completely
from the diet, which is not uncommon in the clinical
practice. Several studies have demonstrated the relation-
ship between vitamin K intake and INR control [38–40]
in particular suggesting patients should be advised to
consume a healthy diet, and they should not avoid fruits
and vegetables for fear of altering the INR.
Despite the evidence, it is common practice to sug-
gest vitamin K free diets to all patients on oral anti-
coagulants therapy. The main consequence of this
recommendation is the exclusion of vegetables and
fruit from the diet, resulting in nutrient deficiencies
and impaired health status. We should not forget that
eliminating these very important food groups puts
our patients at further risk.
In the field of cardiovascular risk and diseases, med-
ical nutrition therapy plays a crucial role in providing
both prevention and therapy. A correct and complete
nutritional assessment is essential for effective therapy.
Nutritional intervention should be tailored to the indi-
vidual patient and should provide the correct amount
of macronutrients, micronutrients and vitamin or min-
eral supplementation if needed.
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